1. Latest News
  2. Submit Press Release

Therapeutic Antibodies: Status, Strategies and Outlook

Therapeutic antibodies are central to pharmaceutical development; needless to say, emphasis is continually on developing new methods and improving those already in place. Play an active role in the war against disease – register online today!

Jan. 13, 2011 - PRLog -- This intensive class begins with a comprehensive overview of antibodies and builds a steady platform of knowledge about the potential development strategies. Having analysed and understood the historical, scientific, technological and legal context surrounding today’s market, delegates can then expect detailed and specific advice on improving generated antibodies from a scientific and business perspective. In this, the longest session in the masterclass, invaluable, tangible expertise and advice will highlight some of the possible ways to get the most out of your antibody projects.

By attending this Masterclass, you will be able to:

Understand the contextual backdrop to the therapeutic antibody industry

Discuss the latest generation of  antibodies and their features

Learn from the advice offered and apply to your own projects

For further information and the opportunity to register online please visit http://www.smi-online.co.uk/antibodiesclass5.asp

# # #

SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information.

--- End ---

Click to Share

Contact Email:
Source:SMi Group
Phone:+44 (0)20 7827 6000
Zip:SE1 0HS
Location:London City - London, Greater - United Kingdom
Tags:Therapeutics, Antibodies, Immunology, Disease, Pharmaceutical, Medical, Drug Development
Verified Account Email Address

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Trending News...

Like PRLog?
Click to Share